CORC  > 吉林大学白求恩第三医院
Novel antibody against oligomeric amyloid-beta: Insight into factors for effectively reducing the aggregation and cytotoxicity of amyloid-beta aggregates
Huai, Yangyang; Cai, Jing; Song, Chuli; Zhang, Yingjiu; Zhang, Xiaoning
刊名INTERNATIONAL IMMUNOPHARMACOLOGY
2019
卷号67
关键词scFv antibody Amyloid-beta Alzheimer's disease Aggregation Cytotoxicity
ISSN号1567-5769
URL标识查看原文
语种英语
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/3511529
专题吉林大学白求恩第三医院
推荐引用方式
GB/T 7714
Huai, Yangyang,Cai, Jing,Song, Chuli,et al. Novel antibody against oligomeric amyloid-beta: Insight into factors for effectively reducing the aggregation and cytotoxicity of amyloid-beta aggregates[J]. INTERNATIONAL IMMUNOPHARMACOLOGY,2019,67.
APA Huai, Yangyang,Cai, Jing,Song, Chuli,Zhang, Yingjiu,&Zhang, Xiaoning.(2019).Novel antibody against oligomeric amyloid-beta: Insight into factors for effectively reducing the aggregation and cytotoxicity of amyloid-beta aggregates.INTERNATIONAL IMMUNOPHARMACOLOGY,67.
MLA Huai, Yangyang,et al."Novel antibody against oligomeric amyloid-beta: Insight into factors for effectively reducing the aggregation and cytotoxicity of amyloid-beta aggregates".INTERNATIONAL IMMUNOPHARMACOLOGY 67(2019).
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace